IMMUNITYBIO
Live / Registered — Registered (as of 22 Nov 2022)
What this means for you
Registered since 22 Nov 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88641668
- Registration number
- 6907469
- Mark type
- Stylized text
- Filed
- 03 Oct 2019
- Published for opposition
- 11 Feb 2020
- Registered
- 22 Nov 2022
- Attorney of record
- Michael J. McCue
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of infectious disease for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of infectious disease; pharmaceutical preparations for the treatment of HIV for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of HIV
Owner
- NANTCELL, INC., CULVER CITY, CA, US
- NANTCELL, INC., CULVER CITY, CA, US
- IMMUNITYBIO, INC., CULVER CITY, CA, US
- IMMUNITYBIO, INC., CULVER CITY, CA, US
- NantCell, Inc., Culver City, CA, US
Prosecution history
- 22 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Sept 2022 — SOU EXTENSION 5 GRANTED
- 16 Sept 2022 — SOU EXTENSION 5 FILED
- 16 Sept 2022 — USE AMENDMENT FILED
- 29 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 16 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 16 Sept 2022 — TEAS STATEMENT OF USE RECEIVED
- 09 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Apr 2022 — SOU EXTENSION 4 GRANTED
- 07 Apr 2022 — SOU EXTENSION 4 FILED